Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo
Authors:
Open Access
- 10 August 2012
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 28 (5) , 1687-1692
Abstract
Vascular endothelial growth factor (VEGF), a crucial promoter of blood vessel growth, not only stimulates endothelial cell proliferation, migration and survival, but also increases vascular permeability. The promotion of angiogenesis is a well-known prerequisite for tumor growth, invasion and metastasis. Evidence has shown that VEGF is overexpressed in many types of tumor tissues. Small interfering RNA (siRNA) targeting VEGF may effectively suppress cell proliferation and induce apoptosis in tumor cells. In this study, we aimed to evaluate whether lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo. The transfection of VEGF siRNA into SGC7901 human gastric cancer cells downregulated the expression of VEGF and Bcl-2, but upregulated the expression of p21. In a nude mouse model of subcutaneous xenografts, 24 days after VEGF siRNA treatment, the tumor volume and weight were significantly smaller in the VEGF siRNA group compared to the control scrambled siRNA group. Furthermore, the expression of VEGF, sirtuin 1 (SIRT1), survivin and Bcl-2 was downregulated, whereas the expression of p53 and p21 was upregulated in the tumor cells, indicating that VEGF siRNA induced apoptosis in gastric cancer cells by inhibiting SIRT1 expression, leading to p53 transcriptional upregulation and the activation of downstream p21, while suppressing Bcl-2 and survivin expression. Our results demonstrate that lentivirus-mediated siRNA targeting VEGF offers a potential strategy to prevent the growth of gastric cancer.Keywords
This publication has 24 references indexed in Scilit:
- Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric CancerPLOS ONE, 2011
- Combination of vascular endothelial growth factor antisense oligonucleotide therapy and radiotherapy increases the curative effects against maxillofacial VX2 tumors in rabbitsEuropean Journal of Radiology, 2011
- Silence of HIN-1 expression through methylation of its gene promoter in gastric cancerWorld Journal of Gastroenterology, 2011
- Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumorsCancer Biology & Therapy, 2010
- Phage-Derived Fully Human Monoclonal Antibody Fragments to Human Vascular Endothelial Growth Factor-C Block Its Interaction with VEGF Receptor-2 and 3PLOS ONE, 2010
- Autocrine Loop between Vascular Endothelial Growth Factor (VEGF)-C and VEGF Receptor-3 Positively Regulates Tumor-Associated Lymphangiogenesis in Oral Squamoid Cancer CellsThe American Journal of Pathology, 2009
- Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2Cell Cycle, 2008
- Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1Frontiers in Bioscience-Landmark, 2007
- A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional networkProceedings of the National Academy of Sciences, 2006
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004